Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Scientific Reports|September 2, 2017
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancerSiv Mjos, Henrica M J Werner, Even Birkeland, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial CarcinomaFrederik Holst, Henrica M J Werner, Siv Mjøs, et al.Oncotarget|October 6, 2017
Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancersAnna Berg, Ankush Gulati, Sigmund Ytre-Hauge, et al.Oncotarget|November 22, 2014
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patientsAnna Berg, Erling A Hoivik, Siv Mjøs, et al.Cancer & Metabolism|June 6, 2019
Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHCGro V Røsland, Sissel E Dyrstad, Deusdedit Tusubira, et al.Retrovirology|November 1, 2012
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genomeHongshuo Song, Jeffrey W Pavlicek, Fangping Cai, et al.Journal of Virology|August 13, 2011
Primary infection by a human immunodeficiency virus with atypical coreceptor tropismChunlai Jiang, Nicholas F Parrish, Craig B Wilen, et al.Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.Plos Pathogens|June 14, 2012
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Nicholas F Parrish, Craig B Wilen, Lauren B Banks, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Phenotypic properties of transmitted founder HIV-1Nicholas F Parrish, Feng Gao, Hui Li, et al.Pageof 4